Information disclosure
06
2023
-
01
Publicity of scientific and technological achievements transformation
Publicity of the transformation of scientific and technological achievements
[2023] No. 1
In accordance with the Law of the People's Republic of China on Promoting the Transformation of Scientific and Technological Achievements, the Administrative Measures for the Transformation Research Project of Shenzhen Bay Laboratory, and the transformation of scientific and technological achievements of Shenzhen Bay Laboratory Pingshan Biomedical R&D and Transformation Center, after the application of the accomplisher, the scientific research review of the Comprehensive Department, and the deliberation of the Director's Office of the Pingshan Center, the patent technology transformation of Li Zigang and other completers is hereby announced as follows:
Outcome Name: A peptide inhibitor for the treatment of triple-negative breast cancer and its preparation method and use
Conversion method: Free license, and at the same time receive and hold 2% of the company's equity
Cooperation company: Shenzhen Junchangyi Biotechnology Co., Ltd
Pricing method: Negotiate pricing after evaluation by a third-party organization. Valuation is ¥54,000.00 CNY.
Income distribution: Shenzhen Shenwan Transformation Investment Co., Ltd. obtained 80% of the income, accounting for 1.6% of the shares; Shenzhen Shenwan Transformation Investment Partnership (Limited Partnership) received 20% of the income, accounting for 0.4% of the shares.
Publicity period: January 2023, 1 to January 6, 2023, a total of 1 days.
Objection handling:
If you have any objections to the above transformation matters, please report to the leaders of the General Department or the center through letters, calls, visits, etc. during the publicity period. Contact Department: General Department; Contact: Xiao Ran; Contact email: xiaoran@szbl.ac.cn. We will keep it strictly confidential and will not be accepted after the deadline.
Form: Information table on results to be transferred
|
serial number |
Patent name |
Type of patent |
Patent number |
Patentee |
Inventor |
Date of application |
|
1 |
Peptide inhibitor for the treatment of triple-negative breast cancer and preparation method and use thereof |
Invention patents |
202210987769.1 |
Shenzhen Bay Laboratory Pingshan Biomedical R&D and Transformation Center |
LI Zigang, YIN Feng, CHEN Hailing, ZHAN Meimiao, LIU Jianbo, KONG Lingwei |
2022/8/17 |
Shenzhen Bay Laboratory Pingshan Biomedical R&D and Transformation Center
2023 Feb 1
Related Information
Notice on Holding a Safety Work Meeting
2022-06-13
E-mail: ptmc@szbl.ac.cn Address: 7-14/F, Block B, Building A, Building 3, High tech Industry University Research Base, No. 16 Lanjing Road, Kengzi Street, Pingshan District, Shenzhen, Guangdong Province Zip code: 518118
Copyright © 2022 Shenzhen Bay Laboratory Pingshan Biopharmaceutical R&D and Transformation Center | SEO
Powered by www.300.cn